We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CUR market cap is 14.01M. The company's latest EPS is USD -1.3345 and P/E is -1.24.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.61M | -3.78M | -3.15M | -3.67M | -4.21M |
| Net Income | -3.39M | -3.6M | -2.97M | -3.53M | -4.08M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 15k | 14k | 0 | 0 | 250k |
| Operating Income | -8.63M | -10.69M | -41.85M | -15.72M | -13.07M |
| Net Income | -8.35M | -16.28M | -26.62M | -14.26M | -12.3M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.29M | 17.07M | 14.05M | 12.65M | 12.87M |
| Total Liabilities | 2.49M | 2.99M | 2.74M | 2.59M | 2.92M |
| Total Equity | 15.8M | 14.08M | 11.31M | 10.06M | 9.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.58M | 13.05M | 12.51M | 15.76M | 14.05M |
| Total Liabilities | 1.46M | 3.28M | 5.15M | 3.28M | 2.74M |
| Total Equity | 5.13M | 9.77M | 7.37M | 12.48M | 11.31M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.73M | -8.39M | -11.13M | -3.18M | -6.68M |
| Investing | -4k | -4k | -4k | N/A | N/A |
| Financing | 9.75M | 11.32M | 11.19M | 2.02M | 5.6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.26M | -9.03M | -14.77M | -13.36M | -11.13M |
| Investing | N/A | N/A | -54k | -10k | -4k |
| Financing | 6.59M | 14.47M | 24.61M | 15.26M | 11.19M |
| Market Cap | 14.01M |
| Price to Earnings Ratio | -1.24 |
| Price to Sales Ratio | 61.25 |
| Price to Cash Ratio | 1.23 |
| Price to Book Ratio | 1.35 |
| Dividend Yield | - |
| Shares Outstanding | 9.22M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.04 (2.47%) |
| Company Name | Neuralstem Inc |
| Address |
2140 s dupont hwy camden, delaware 19934 |
| Website | https://www.palisadebio.com. |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
